Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein by Del Val, Margarita et al.
Cell, Val. 66, 1145-1153, September 20, 1991, Copyright © 1991 by Cell Press 
Efficient Processing of an Antigenie Sequence 
for Presentation by MHC Class I Molecules Depends 
on Its Neighboring Residues in the Protein 
Margarita Dei Val, Hans-Jürgen Schlicht, 
Thomas Ruppert, Matthias J. Reddehase, 
and Ulrich H. Koszinowski 
Department of Virology 
University of Ulm 
Albert-Einstein-Allee, 11 
7900 Ulm 
Federal Republic of Germany 
Summary 
Processing of endogenously synthesized proteins 
generates short peptides that are presented by MHC 
class I molecules to CD8 T Iymphocytes. Here it is doc-
umented that not only the sequence of the presented 
peptide but also the residues by which it is flanked in 
the protein determine the efficiency of processing and 
presentation. This became evident when a viral se-
quence of proven antigenicity was inserted at different 
positions into an unrelated carrier protein. Not differ-
ent peptides, but different amounts of the antigenic 
insert itself were retrieved by isolation of naturally pro-
cessed peptides from cells expressing the different 
chimeric proteins. Low yield of antigenic peptide from 
an unfavorable integration site could be overcome by 
flan king the insert with oligo-alanine to space it from 
disruptive neighboring sequences. Notably, the de-
gree of protection against let hai virus disease related 
directly to the amount of naturally processed antigenic 
peptide. 
Introduction 
Cytolytic T Iymphocytes (CTLs) of the CD8 subset recog-
nize short peptides that are derived by processing from 
intracellular proteins and presented at the cell surface by 
major histocompatibility complex (MHC) class 1 molecules 
(Townsend et al., 1986b; reviewed in Townsend and 
Bodmer, 1989). External addition of synthetic peptides to 
cells has shown that MHC class I molecules can bind and 
present to CTLs of defined specificity not only one particu-
lar peptide but also aseries of analogs thereof that differ 
in length and antigenic potency. As opposed to this experi-
ence, naturally processed peptides retrieved from cells 
that synthesize the respective antigenic protein appear to 
be of rather limited diversity (Van Bleek and Nathenson, 
1990; Rötzschke et al. , 1990a, 1990b). The underlying 
principles are not fully understood, although it seems clear 
that the MHC molecules themselves playa decisive role 
in endogenous peptide selection, because a peptide pre-
sented by a particular MHC class I molecule cannot be 
isolated from cells that do not express this MHC molecule 
(Falk et al., 1990). Earlier steps in the generation of anti-
genic peptides involving cleavage of proteins by proteases 
are largely undefined (Yewdell and Bennink, 1990). 
There is ample evidence that processing and presenta-
tion of antigenic peptides are not dependent on the intra-
cellular destination and the physiologic function ofthe anti-
genic protein (Townsend et al. , 1986a; Braciale et al., 
1987; Volkmer et al. , 1987). The antigenic sequence can 
even be part of a chimeric protein (Chimini et al. , 1989; Dei 
Val et al., 1991). Until now the data were in accordance 
with the view that the sequence of the presented peptide 
is the only determinative parameter for its presentation. 
Based on this assumption, algorithms have been pro-
posed for predicting antigenicityfrom sequence character-
istics (DeLisi and Berzofsky, 1985; Rothbard and Taylor, 
1987). Yet now the predictive value of these algorithms 
has proven to be limited. 
An influence on antigen processing and presentation of 
residues that flank the finally presented antigenic peptide 
in the protein would explain failures of antigenicity predic-
tions. We have therefore tested whether the amino acids 
that flank a sequence of defined antigenic potency have 
an effect on its processing and presentation. For this pur-
pose we used the nonapeptide sequence 168YPHFMP_ 
TNL 176 (one-Ietter code), which is presented by the murine 
MHCclass I molecule Ld(Del Val et al. , 1988, 1989; Redde-
hase et al., 1989) and represents for CTLs of the BALBtc 
strain the only antigenic site recognized in the IE1 protein 
pp89 (Volkmer et al., 1987; Dei Val et al. , 1991), a regula-
tory protein of murine cytomegalovirus (MCMV) (Keil et al. , 
1987). CD8 T Iymphocytes specific for that protein protect 
against lethai MCMV infection (Jonji6 et al., 1988), and 
protective immunity is also induced by chimeric proteins 
that contain only the nonapeptide of pp89 as insert (Dei 
Val et al., 1991). By placing this sequence into different 
positions of an unrelated carrier protein, we tested a possi-
ble position al effect on antigen presentation and used pro-
tection of mice against lethai virus challenge as a means 
to estimate its biological relevance. 
Two findings are described. First, amino acids that flank 
an antigenic sequence in the protein can have a profound 
positive or negative effect on antigen processing and pre-
sentation, both in cell culture and in vivo. Second, differ-
ences in presentation efficiency reflected differences in 
the amount of naturally processed peptide. 
Results 
The Position within a Protein Is Determinative for 
Presentation of an Antigenic Sequence 
If antigen processing is governed only by the antigenic 
sequence itself, then presentation of a peptide of defined 
antigenic potency by the restricting MHC molecule should 
be independent of its location in the antigenic protein from 
wh ich it is derived by endogenous processing. To test this 
prediction, chimeric genes were constructed that con-
tained the coding sequence for the antigenic nonapeptide 
'68YPHFMPTNL'76 at different positions of the hepatitis B 
virus core antigen (HBcAg) gene. This peptide was identi-
fied previously as the optimal antigenic peptide presented 
by the MHC class I molecule L d to clonal (Reddehase et 
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Figure 1. Schematic Representation and Amino Acid Sequence 01 
pp89 and Chimeric Proteins 
(A) Proteins are represented by open bars with numbers indicating 
amino acid positions. pp89-deriyed antigenie sequences within chi-
meric proteins are shown as closed boxes not drawn to the same 
scale as the proteins. Their length and Ilanking alanine residues are 
depicted. 
(B) Amino acids are giyen in one-Ietter code. Capital letters indicate 
native pp89 sequences. Underlined lowercase letters reler to amino 
acids encoded by linker sequences lor restrietion endonucleases intro-
duced during the construction 01 the chimeric genes. Nonunderlined 
lowercase letters identify sequences Irom the carrier proteins. Chi-
meric proteins are named by citing lirst the carrier protein, then the 
IDeation 01 the insert, and linally the length 01 the pp89 sequence. 
Penta-alanine nanking is indicated. Asterisks mark Ihe chimeric pro-
teins described preyiously (Dei Val et al. , 1991). 
al., 1989) as weil as polyclonal (Dei Val et al. , 1991) CTLs 
specific for the IE1 protein pp89 of MCMV. The chimeric 
genes were recombined into the genome of vaccinia virus. 
In Figure 1 A the constructs are represented schematically, 
and in Figure 1 B the sequences are listed. 
In one approach (Figure 1A, top), the nonapeptide se-
quence (from now on referred to as 9-mer) and an 18-mer, 
comprising the 9-mer with authentie flan king residues, 
were translocated from their natural position within pp89 
to a position close to the C-terminus. This was accom-
plished by inserting these sequences into amino acid posi-
tion 553 of mutant ßF of pp89, in which the antigenie re-
gion is deleted from position 136-249 (Dei Val et al., 1988). 
Presentation occurred from ßF/9-mer (Dei Val et al. , 1991) 
and ßF/18-mer (Figures 3A and 3B, respectively) with no 
apparent difference to the presentation from authentie 
pp89 expressed in cells infected with the recombinant 
MCMV-iel-VAC (Volkmer et al., 1987) (Figure 3A). 
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Figure 2. Expression 01 Chimeric Proteins in Cells Inlecled with Re-
combinant Vaccinia Viruses 
Western blot analysis with hepatitis B yirus-specilic antiserum. 
(A) Proteins lrom cells inlected with the indicated recombinant Yiruses. 
(B) Proteins secreted into the culture medium. Lane a, HBcAg; lane b, 
HBeAg; lane c, HBc/C-end/l8-mer; lane d, HBc/N-end/18-mer; lane e, 
HBc/C-end/9-mer; lane f, HBc/C-end/A,9-merA,; lane g, HBc/N-end/ 
9-mer; lane h, HBe/N-endl9-mer; la ne i, HBe/N-end/A.9-merA,; lane i, 
HBc/C-end/7-mer; lane k, HBe/C-end/A,7-merA.; lane I, HBe/N-endl 
A.7-merA •. AbbreYiations are as in Figure 1. 
In another approach (Figure 1 A, bottom), the two peptide 
sequences were inserted into an unrelated carrier protein, 
HBcAg, either close to the C-terminus at position 179 
(HBc/C-end/9-mer and HBc/C-end/18-mer) or close to the 
N-terminus at position 3 (HBc/N-end/9-mer and HBc/ 
N-end/18-mer). While presentation occurred from both 
18-mer constructs (Figure 3B), a striking difference was 
seen for the two 9-mer constructs in that C-terminal inte-
gration was permissive for presentation of the inserted 
antigenie sequence, whereas N-terminal integration was 
unfavorable (Figure 3A). 
The overall amount of chimeric protein synthesized in 
cells after infection with the vaccinia recombinants was 
controlled by Western blot and was found to be compara-
ble in all cases considered (Figure 2), and, specifically, 
also for construct HBc/N-end/9-mer (Iane g). Shifts in elec-
trophoretic mObility of the chimeric proteins in relation to 
the carrier proteins chiefly correlated with the number of 
inserted amino acids, except that proteins containing in-
sertions at the C-terminus had a slightly higher mObil ity 
than those with insertions at the N-terminus (Figure 2A, 
compare lanes c and e with lanes d and g, respectively) . 
This might be due to an altered phosphorylation at a C-ter-
minal position of HBcAg close to the integration site (Ganem 
and Varmus, 1987). In conclusion, the low efficiency of 
antigen presentation from HBc/N-end/9-mer cannot be ex-
plained by a reduced amount of protein available for pro-
cessing. 
To preclude any effect imposed by the vaccinia virus 
vector system, such as that studied by Townsend et al. 
(1988), L1Ld cells were transfected with plasmids encoding 
the chimeric proteins HBc/N-end/18-mer and HBc/N-end/ 
9-mer. Again, N-terminallocation of the 9-mer resulted in 
poor antigenicity (Figure 3C), which clearlyindicates that 
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Figure 3. Effeet 01 Flanking Residues on Antigen Presentation Irom 
Chimerie Proteins 
Reeognition by ppB9-speeilieCTLs 01 BALB,SV eellsthat were inleeted 
with reeombinant vaeeinia viruses (A and B) or 01 UL' eells that were 
transleeted with reeombinant plasmids (C) eneoding authentie ppB9 
or ehimerie proteins as indicated: open squares, ppB9; hall-lilled trian-
gles, llF/9-mer; filled triangles, HBe/C-end/9-mer; open triangles, 
HBe/N-end/9-mer; hall-lilled cireles, llF/1B-mer; filled eireles, HBel 
C-end/1B-mer; open eireles, HBe/N-end/1B-mer; open diamonds, llF; 
li lied diamonds, HBeAg, 
this integration site is unfavorable for presentation of the 
9-mer, irrespective of the vector system employed. 
Collectively, these findings thus provided an example 
of a positional effect in antigenic peptide processing and 
presentation. 
Proximity to the N-Terminus Does Not Account 
tor Poor Antigenicity 
An apparent difference between HBc/N-end/18-mer and 
HBc/N-end/9-mer is the distance between the N-terminal 
methionine of the carrier protein and the first residue of 
the 9-mer, which is a tyrosine (Figure 1 B). If the mere 
proximity of the N-terminus to the core of the antigenic 
sequence were incompatible with efficient antigen presen-
tation, for any reason whatsoever, any means of spacing 
should restore antigenicity. We chose the following ap-
proach to the problem: the hepatitis B virus precore protein 
differs from HBcAg byan additional N-terminal sequence 
of 29 amino acids, the pre-C region (Ganem and Varmus, 
1987), which functions as a signal for secretion and medi-
ates the translocation of the precore protein ac ross the 
membranes of the endoplasmic reticulum. By removal of 
the 19 N-terminal pre-C amino acids, and of a portion ofthe 
C-terminus, the precore protein is converted into HBeAg, 
wh ich is then actively secreted (Ou et al., 1986). Thus, the 
9-mer, when cloned into hepatitis B virus precore protein, 
is flanked by 10 additional N-terminal residues in the re-
sulting chimeric HBeAg. As a consequence of the N-termi-
nal insertion, chimeric proteins with lower electrophoretic 
mObility than expected from the number of inserted amino 
acids were accumulated and secreted (Figure 2, compare 
lane b with lane h), wh ich suggests an interference with 
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Figure 4, Restoration 01 Effieient Antigen Presentation by Penta-
Alanine Flanking 01 the Antigenie Sequenee 
Reeognition by ppB9-speeilie CTLs 01 BALB.SV eells inleeted with 
reeombinant vaeeinia viruses eneoding ehimerie proteins that eontain 
ppB9 sequenees: open triangles, HBe/N-end/9-mer; inverted hall-lilled 
triangles, HBe/N-end/9-mer; Iilled triangles, HBe/C-end/9-mer; in-
verted li lied triangles, HBc/C-end/As9-merA5; inverted open triangles, 
HBe/N-end/A59-merAs; Iilled squares, HBe/C-end/7-mer; hall-lilled dia-
monds, HBe/C-end/As7-merAs; open diamonds, HBe/N-endlAs7-merAs. 
correct removal of the C-terminal portion of HBeAg. The 
finding that presentation to CTLs of the antigenic se-
quence was equally poor from HBe/N-end/9-mer and HBc/ 
N-end/9-mer (Figure 4A) argues against a critical influence 
of the distance to the N-terminus of the carrier protein. It 
should be noted that here and in further experiments HBe-
and HBc-based constructs proved to be fully interchange-
able. This finding is in accordance with previous experience 
that antigen processing is not dependent on the intracellu-
lar destination of the antigenic protein (Townsend et al., 
1986a; Braciale et al., 1987; Volkmer et al., 1987). 
Oligo-Alanine Spacing Can Avoid Untavorable 
Flanking and Restores Presentation 
At this stage, an influence of the linker and carrier protein 
sequences directly flanking the antigenic insert (see Fig-
ure 1 B) appeared to us the most likely explanation for the 
observed positional effect on antigen presentation. If this 
were true, creation of a permissive flanking by proper sub-
stitutions should be possible. Instead of performing nu-
merous trial and error substitutions, we preferred another 
approach: it was known from previous experience with 
synthetic peptides that flanking of the 9-mer with alanines 
leaves its antigenic potency essentially unchanged (data 
not shown). Flanking with alanines could therefore serve 
to space the antigenic sequence from unfavorable neigh-
boring residues. In accordance with previous data (Dei Val 
et al., 1991), penta-alanine flanking in HBc/C-end/As9-
merAs did not disturb presentation from a permissive site 
(Figure 4B). Yet, remarkably, penta-alanine flanking in 
HBe/N-end/As9-merAs converted the N-terminal site from 
an unfavorable into a favorable site for antigen processing 
and presentation (Figure 4C). 
Earlier work has shown that the heptapeptide sequence 
'69PHFMPTN '75 is not presented from intracellularly syn-
thesized pp89-t1F- or HBc-based chimeric proteins (Dei 
Val et al., 1991) even though this peptide (Reddehase et 
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Figure 5. Induction of Protective Immunity by Recombinant Vaccinia 
Viruses Encoding Chimeric Proteins 
Mice were immunized with recombinant vaccinia viruses encoding the 
indicated proteins and were challenged 3 weeks later with 3 LD50s of 
MCMV. Protection is expressed on the vertical axis as percentage of 
surviving mice. The aclual number of mice in each group (survivorsf 
10lal lesled) is indicated on lop of each column. Dala are compiled 
from seven independenl experiments. Significance was calculaled 
by applying Fisher's exact probability test: column B vs. C, significant, 
p < 0.0001; B vs. E, signifieanl, p = 0.0003; E vs. F, not signifieanl, p 
= 0.1481; B vs. D, not significanl, p = 0.2865; D vs. G, signifieanl, 
p = 0.0003. 
al. , 1989) and the alanine-flanked analog APHFMPTNA 
(Reddehase and Koszinowski, 1991) are antigenic when 
externally added to L d-expressing cells. We therefore won-
dered whether the strategy of oligo-alanine spacing would 
also help the heptapeptide sequence to get presented. 
This was not the case (Figure 40). The affinity of the hepta-
peptide to L dis at least two orders of magnitude lower than 
that of the 9-mer (Reddehase and Koszinowski, 1991), 
and, since alanine flanking does not increase the affinity, 
we speculate that in this case not the flan king residues but 
the low affinity to Ld of the antigenic sequence itself is 
responsible for the failure in presentation. 
In conclusion, oligo-alanine spacing cannot overcome 
insufficient antigenicity of a peptide sequence, but it can 
help avoid negative influences of neighboring residues on 
an optimal antigenic sequence. 
The Efficiency of Antigen Presentation Is Critical 
for the Induction of Protective Immunity 
Thus far, the simian virus 40-transformed ceilline BALB.SV 
was used for studying antigen presentation, and, there-
a b c d e 
---
fore, one could argue that the data have characterized the 
processing and presentation properties of this particular 
ceilline rather than having described a principle. No single 
cell line can apriori be considered representative of the 
cells that process the chimeric proteins in vivo. It has been 
shown in previous re ports that protection induced by pp89 
or the 9-mer thereof is mediated solely by T Iymphocytes 
of the CD8 subset (Jonji6 et al., 1988; Dei Val et al., 1991). 
Therefore, an unambiguous way to test the in vive rele-
vance of the in vitro findings was to probe the quality of the 
various recombinants in protecting against lethai MCMV 
infection (Figure 5). In accordance with previous work (Dei 
Val et al. , 1991), the 9-mer, when integrated at the C-termi-
nus of HBcAg in the construct HBc/C-end/9-mer, was suffi-
cient to induce significant protective immunity. The two 
18-mer constructs induced a similar degree of protection, 
whereas N-terminal integration of the 9-mer in HBc/N-endl 
9-mer failed in protection. Induction of pp89-specific T Iym-
phocytes with the laUer recombinant could only be de-
tected after selective secondary restimulation in vitro (data 
not shown). Finally, as was the case with target cell forma-
tion, penta-alanine flan king in HBe/N-end/As9-merAs suc-
cessfully restored also the protective capacity in vivo. In 
conclusion, the differences in antigen presentation effi-
ciencies as seen in vitro in terms of target cell formation 
for recognition by CTLs are directly reflected by the quality 
of the respective recombinants to induce protective CD8 T 
Iymphocytes, wh ich demonstrates that antigen processing 
and presentation follow the same rules in the cell types 
that are relevant in vivo. 
Differences in Antigen Presentation Efficiency Can 
not Be Explained by Differences in the Overall 
Stability of the Chimeric Proteins 
In vaccinia virus-infected cells, antigen presentation can 
be improved by increasing the overall degradation rate of 
antigenic proteins (Townsend et al., 1988). We therefore 
studied whether poor presentation from the construct HBcl 
N-end/9-mer was associated with high stability of the re-
spective chimeric protein. Infected cells were pulsed with 
[3SS)methionine and chased for various periods of time. 
The HBc/N-end/9-mer chimeric protein had a similar sta-
bility as HBc/N-end/18-mer (Figure 6, compare [eI and [cD, 
regardless of the fact that it was presented much less 
efficiently to CTLs. Likewise, in the comparison of the two 
HBe-based constructs, restoration of efficient antigen pre-
sentation by penta-alanine flanking in HBe/N-end/A59-
9 
---
o 4 hours 
Figure 6. Slability of Chimeric Proleins in 
Cells Infeeled wilh Recombinant Vaccinia Vi-
ru ses 
BALB.SV cells were labeled for 30 min with 
[35S1melhionine 8 hr after infection with Ihe dif· 
ferenl recombinanl viruses and chased in Ihe 
presence of nonradioactive methionine for 0, 
1, and 4 hr, as indicated. Ceillysales were Ihen 
immunoprecipilaled wilh H BcfHBe-specific an-
tiserum. (a) HBcAg; (b) HBeAg; (c) HBcfN-end/ 
18-mer; (d) HBc/C-end/9-mer; (e) HBc/N-end/9-
mer; (f) HBe/N-end/9-mer; (g) HBe/N-end/As9-
merAs. Abbrevialions are as in Figure 1. 
Positional Effect in Antigen Processing 
1149 
A 
40 
20 
B 
40 
20 
I c 
40 25 
'" ! 20 ~ 
l 
CI) 0 
# 40 
---
-25 
20 
E 25 
40 
20 
15 25 
Fr.cIIon numbIr 
YPHFMPTl\IL 10 
eo 
30 
10 
eo 
30 
~ 10 
eo .!! 
i 
30 j 
~ 10 # 
eo 
30 
HhtHndI 10 
'''r,9m«''s 
eo 
30 
35 45 
Figure 7. Naturally Processed Peptides from Chimeric Proteins Co-
elute with the Synthetic Nonapeptide 
(A) The synthetic nonapeptide was subjected to reverse-phase HPLC 
and eluted in an acetonitrile gradient. Vertical bars indicate the elution 
positions of related peptides: (a) 7-mer PHFMPTN; (b) 8-mer 
YPHFMPTN; (c) 8-mer PHFMPTNL; (d) 10-mer YPHFMPTNLG; (e) 
10-mer MYPHFMPTNL; (f) 18-mer RLMYDMYPHFMPTNLGPS. 
(B-E) BALB.SV cells were infected with recombinant vaccinia viruses 
expressing the indicated proteins. Acid-soluble molecules were ex-
tracted and separated first by gel filtration chromatography and then 
by reverse-phase HPLC. Fractions were tested in triplicate with pp89-
specific CTLs for their content of antigenic peptides. 
merAs was not accompanied by an increased protein deg-
radation rate (Figure 6, [f) and [g)). It was therefore 
concluded that the overall stability of the chimeric proteins 
did not account for the differences in efficiency of antigen 
presentation observed in vitro as weil as in vivo. 
Processing from an Unfavorable Site Leads to a 
Lower Amount of Naturally Processed Peptide 
What is the molecular explanation for the observed differ-
ences in target cell formation and in vive T Iymphocyte 
sensitization? Antigen presentation requires that the anti-
genie protein is properly cleaved so as to not destroy the 
antigenic site and to generate peptide(s) that can bind 
to the presenting MHC molecules. If natural processing 
generates peptides that are longer than the inserted opti-
mal antigenic sequence, then processing from the various 
chimeric proteins, all of which provide their individual 
flanking residues (see Figure 1 B), would lead to different 
peptides that are likely to differ in their binding affinity 
for Ld and will thus be presented with different efficiency. 
Accordingly, reduced antigen presentation from an unfa-
vorable site can have two reasons: processing could gen-
erate a lower amount of the optimal antigenic peptide, or 
could generate longer, suboptimal peptide(s). 
The recently described method of extracting naturally 
processed peptides from cells (Rötzschke et al. , 1990b) 
should give the information whether after processing of 
the chimeric proteins the same peptide or different pep-
tides can be recovered. Naturally processed peptides 
were acid extracted from infected cells and analyzed 
by reverse-phase high pressure liquid chromatography 
(HPLC). As a reference, the optimal synthetic nonapeptide 
was also subjected to HPLC and was found to elute in an 
acetonitrile gradient as one dominant peak of biological 
activity (Figure 7A), corresponding to the only peak de-
tected spectrophotometrically (data not shown). Also indi-
cated in Figure 7 Aare the elution properties of a relevant 
set of related peptides of different lengths, none of which 
coeluted with the nonapeptide. The activity of naturally 
processed peptides extracted from cells infected with 
MCMV-iel-VAC, encoding authentic pp89, and the vac-
cinia recombinant HBc/C-end/9-mer, containing the 9-mer 
at a permissive site ofthe unrelated carrier protein HBcAg, 
was of comparable intensity and coeluted in both cases 
with the synthetic nonapeptide in fraction 25 (Figures 7B 
and 7C, respectively). Notably, insertion into the unfavor-
able site in HBc/N-end/9-mer resulted in a lower activity, 
yet again, in the same fraction (Figure 70), and rescue 
of presentation by penta-alanine flan king in HBe/N-end/ 
As9-merAs restored the activity retrieved from the cells 
(Figure 7E). 
Based on the identity of the elution characteristics, it 
appeared to us reasonable to assume that biological activ-
ity relates directly to the amount of extracted peptide. On 
this premise, processing from the unfavorable construct 
H Bc/N-end/9-mer was quantitated and compared with pro-
cessing from the rescue construct HBe/N-end/As9-merAs 
and from the favorable construct HBc/C-end/9-mer, by di-
luting fraction 25 of the respective HPLC runs before the 
cytolytic assay. The difference in cell number needed for 
peptide extraction to get at comparable activity was about 
16-fold between the poorly presented and the two effi-
ciently presented chimeric proteins (Figure 8). 
In conclusion, inefficient antigen presentation can be 
explained by the generation of a lower amount of naturally 
processed peptide. 
Discussion 
Insertion of a nonapeptide sequence of defined antigenic-
ity into different positions of an unrelated carrier protein 
has demonstrated a critieal role of flan king residues in 
determining the efficiency of antigen processing and pre-
sentation. This finding has important implications for the 
predictability of antigenic sites in proteins, for the design 
of recombinant vaccines, and for the understanding of 
principles that govern antigen processing and peptide pre-
sentation. 
From the compilation of amino acid sequences of empiri-
cally identified antigenic peptides, algorithms have been 
formulated to predict antigenic sequences recognized by 
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Figure 8. Penta-Alanine Flanking Increases the Yield ot Processed 
Antigenic Peptide 
Naturally processed peptides were acid extracted trom cells intected 
with the recombinants HBc/N-end/9-mer (open triangles). HBc/C-endl 
9-mer (filled triangles). and HBe/N-end/As9-merAs (inverted open trian-
gies) and were separated by gel filtration tollowed by reverse-phase 
HPLC. Serial dilutions of fraction 25 of the HPLC runs were tested in 
the cytolytic assay. The calculated number of intected cells from which 
peptides were recovered is given on the horizontal axis. and percent 
specific lysis is given on the vertical axis as a measure of the amount 
of the relevant antigenic peptide. 
T Iymphocytes. These algorithms are being used to screen 
protein sequences for certain motifs. Motifs indicate the 
propensity of a peptide to adopt a particular sterical config-
uration (DeLisi and Berzofsky, 1985) or represent a pattern 
of residues with a typical polarity distribution (Rothbard 
and Taylor, 1987). Yet, even though successfully em-
ployed in some cases, these algorithms have been of lim-
ited predictive value. This does not imply that the al go-
rithms are wrong, but may indicate that other parameters 
in addition to the sequence of an antigenic peptide are 
critically involved in its generation and presentation. An 
immediate idea for explaining the failures of antigenicity 
predictions is that different allelic MHC moleeules show 
subtle preferences for structural features of peptides that 
cannot be included in a general prediction model. Yet, if 
this were the only reason, then a peptide with defined 
affinity for a particular presenting MHC class I molecule 
should always be presented regardless of the position in 
the protein from which it is derived by processing. Our 
results show that this is not the case. Of the two positions 
chosen at random in the unrelated carrier protein HBcAg, 
one was permissive for processing and presentation of 
the antigenic nonapeptide insert, whereas the other was 
unfavorable. This finding unambiguously documents that 
proven antigenicity of an amino acid sequence is no guar-
antee for its adequate processing in the cell. Thus, in the 
cases of failure, prediction algorithms may have correctly 
predicted a potentially antigenic sequence, which, how-
ever, remained nonantigenic and consequently invisible 
in assays because an unfavorable position in the protein 
precluded the generation of the respective peptide. 
The finding that residues that flank an antigenic insert 
have a critical influence on its proper processing compli-
cates the design of recombinant vaccines. One either has 
to test several insertion sites by trial and error or to learn 
the rules that make flan king residues permissive or non-
permissive, which may be cumbersome as the role of 
flanking residues may depend on the sequence of the in-
sert. A sort of "neutral spacing" to separate the insert from 
disadvantageous influences of its neighboring residues 
could be an easier solution to the problem. In our example, 
unfavorable insertion was overcome by penta-alanine 
flan king of the antigenie insert. Systematic analysis will 
have to define whether or not oligo-alanine flan king is gen-
erally applicable, that is, for other antigenic sequences, 
other carrier proteins, and other presenting MHC mole-
cules. 
Wh ich are the peptides generated by natural pro-
cessing? Are they different for the different chimeric pro-
teins, or is the antigenie insert itself retrieved in all cases? 
The main biological activity extracted from cells infected 
with four different recombinants eluted in all four cases in 
the same fraction and, moreover, coeluted with the syn-
thetic nonapeptide. If peptides longer than the 9-mer were 
generated by natural processing from the chimeric pro-
teins, they all should differ from each other, because in 
all of them the 9-mer insert is provided with essentially 
different flankings (see Figure 1 B). In accordance with oth-
ers (Rötzschke et al., 1990a) we have had the experience 
that longer or shorter peptides elute in different fractions. 
This was true for the 18-mer and 7-mer, for two octapep-
tides, and even for the two decapeptides in wh ich the nona-
peptide is flanked on one side by only one authentic resi-
due. Even though one cannot exclude the possibility that, 
by chance, two different peptides coelute, the probability 
that four different longer peptides from the four recombi-
nants all coelute with the nonapeptide is very low. This 
strongly argues against longer peptides being the finally 
presented ones. 
The idea that peptides shorter than the 9-mer are pre-
sented can also be refuted, because the 7-mer, wh ich is 
the most antigenic peptide among the shorter analogs 
(Reddehase et al. , 1989), not only eluted as synthetic pep-
tide in a different fraction, but also was not presented from 
chimeric proteins in which it constituted the insert. The 
mullitude of proteins synthesized in the vaccinia virus ex-
pression system precluded the approach of natural pep-
tide sequencing employed by Van Bleek and Nathenson 
(1990), but the evidence is close to proof that the inserted 
nonapeptide is, in fact, the dominant natural antigenic pep-
tide. In light of recent emphasis given to an observed dis-
crepancy between a synthetic peptide and the correspond-
ing naturally processed peptide (Rötzschke et al., 1990a), 
the concordance seen in our case was not apriori predict-
able. The example shows that a discrepaney between nat-
ural peptides and predietions obtained with synthetic pep-
tides cannot be taken for a prineiple. We rather think that 
accurate definition of the optimal peptide by systematic 
biterminal shortening of an antigenic sequenee (Redde-
hase et al. , 1989) can correetly predict the naturally pro-
cessed peptide. It is also worth mentioning that the few 
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other natural peptides described so far (Van Bleek and 
Nathenson, 1990; Rötzschke et al., 1990a; Falk et al. , 
1991) are also nona- or octapeptides. 
How do flanking residues influence the efficiency of en-
dogenous processing and what can our example contrib-
ute to the understanding of the still unknown processes of 
antigenie peptide generation and presentation? The cur-
rent opinion is that antigen processing and presentation 
include at least four steps: first, partial degradation of the 
antigenie protein, supposedly in the cytosol; second, 
transport of peptides into the endoplasmic reticulum; third, 
loading of MHC class I moleeules to form a trimolecular 
complex of MHC class I heavy chain, peptide, and ß2-mi-
croglobulin; and, fourth, transport of the complex to the 
cell surface (Yewdell and Bennink, 1990; Parham, 1990; 
Townsend et al., 1989). Poor presentation from the unfa-
vorable integration site in HBc/N-end/9-mer was found to 
be associated with a low amount of recoverable antigenie 
peptide. We see four possibilities for explanation. First, the 
reduced amount could result already from an inefficient 
overall protein cleavage as in the example given by Town-
send et al. (1988). In the case reported here, insertions 
in HBcAg led to slightly different stability of the chimeric 
proteins, but there was no correlation between protein sta-
bility and amount of naturally processed peptide. 
Second, the type of residues flanking the antigenie se-
quence may codetermine the local protein conformation 
atthe antigenie site, and thereby affectthe local accessibil-
ity for proteases, or may directly account for the presence 
or absence of cleavage signals for proteases. In both in-
stances, flan king can be favorable or unfavorable for the 
efficient release of the correct and intact antigenie se-
quence from the protein. A putative conformational effect 
on local cleavage efficiency is difficult to prove or refute, 
and from our examples of efficient presentation from chi-
meric proteins we do not recognize a consensus in the 
flan king sequences that could promote cleavage. Future 
tests will have to show which of the flan king residues, 
alone or in combination, are responsible for the poor pre-
sentation from HBc/N-end/9-mer. One could consider, for 
instance, the two-sided flanking byglycines and negatively 
charged residues, as is the case in this construct. 
The third possibility to explain poor presentation is that 
the recently discussed peptide transporters (Parham, 
1990) might select peptides by unknown criteria. 
The fourth possibility is that longer peptides are excised 
from the protein in the first place, get transported, associ-
ate with Ld, and are then trimmed to the finally presented 
peptide, a mechanism discussed as one possibility to ex-
plain how MHC class I moleeules select and protect pep-
tides from complete degradation (Falk et al., 1990). That 
MHC class I moleeules playa decisive role in peptide se-
lection is based on the finding that a particular antigenie 
peptide can only be extracted from cells that express the 
corresponding presenting MHC moleeule (Falk et al. , 
1990). The same is true for the peptide derived from pp89, 
since no biological activity was recovered from infected 
cells of the mutant mouse strain BALB/c-H-2dm2, in wh ich 
the Ld gene is deleted (unpublished data). According to this 
mechanism, longer peptides, in which flanking residues 
modulate the binding affinity to Ld, will be protected to 
different degrees from degradation. The bound fraction is 
then trimmed, thereby yielding different amounts of only 
one dominant peptide from the various chimeric proteins. 
In conclusion, residues that directly flank the antigenie 
sequence in a protein critically influence the amount of 
naturally processed and presented antigenie peptide. The 
demonstration that the degree of protection against lethai 
disease achieved with the recombinants relates directly to 
the amount of correctly processed peptide underlines the 
importance of the findings. 
Experimental Procedures 
Mice 
BALB/c mice (H-2" haplotype) were bred in our colony under specific 
pathogen-Iree conditions. 
Cells 
BALB.SV, a continuously growing libroblast ceilline, was isolated Irom 
primary cultures 01 BALB/c mouse embryo libroblasts that were in-
lected with wild-type simian virus 40. 
Recombinant Vaccinia Vlruses 
The recombinant vaccinia virus MCMV-ie/-VAC encodes pp89 (Volk-
mer et al. , 1987). The recombinant MCMV-ie/(t>F)-VAC, also referred 
to as t>F, encodes a deletion mutant 01 pp89 that lacks amino acids 
136-249 and therelore does not contain any epitope recognized by 
BALB/c CTLs (Dei Val et al., 1988). 
Insertion of pp89 Antigenic Sequences into 
Hepatitis B Virus Genes 
An HBcAg gene was used, the 5' end of which is derived Irom a syn-
thetic gene (Nassal, 1988) and therelore contains a Clal site 1 codon 
downstream 01 the HBcAg initiation codon. This restrietion site was 
used lor the insertion 01 synthetic oligonucleotides encoding pp89 
antigenic sequences. For insertions in the HBeAg gene (Ganem and 
Varmus, 1987), the same restrietion site was used. In addition, the 
initial AUG codon for HBcAg was converted into AUA by site-directed 
mutagenesis, in order to prevent translation initiation at this position 
(Schlicht and Schaller, 1989). For insertions atthe 3' end ofthe HBcAg 
gene, a natural Aval site located 5 codons upstream 01 the termination 
codon was used. All constructs were conlirmed by sequencing belore 
their recombination into vaccinia virus, under the control 01 the early-
late P7.5K promoter, as described (Volkmer et al., 1987). 
Insertion of pp89 Antigenic Sequences into 
Deletion Mutant t>F 
To reintegrate pp89 sequences at a different position 01 pp89, deletion 
mutant t>F was chosen. A unique Bglli site in the 3' end 01 the t>F 
reading Irame (Keil et al. , 1987; Dei Val et al., 1988), at codon number 
553, was used as insertion si te lor synthetic oligonucleotides. All con-
structs were sequenced and then recombined into vaccinia virus. 
Expression olthe chimeric proteins in cells inlected with the vaccinia 
recombinant viruses was tested by Western blot as described (Dei Val 
et al., 1991). 
Transfection 
UL" cells, which are derived !rom mice 01 H-2' haplotype and were 
translected with the gene lor the MHC class I molecule L" (Ponta et al. , 
1985), were supertransfected with plasmids encoding the chimeric 
protein HBc/N-endI18-mer or HBc/N-end/9-mer under the control 01 
the metallothionein promoter (Junker et al.. 1987). For selection 01 
translected colonies, a plasmid carrying the gene lor neomycin resis-
tance was cotransfected (Colbere-Garapin et al., 1981). 
Synthetic Peptides and Ollgonucleotides 
Peptides were synthesized in an Applied Biosystems peptide synthe-
sizer model 431A and analyzed by reverse-phase HPLC. Oligonucleo-
tides were synthesized in an Applied Biosystems oligonucleotide syn-
thesizer model 381A. 
Cell 
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Cytolytic Assays 
BALB.SV cells were used for infection with recombinant vaccinia vi-
ruses to produce target cells as described (Dei Val et al., 1988). pp89-
specific CTLs were generated by in vitro restimulation with purified 
MCMV of spleen cells from mice that had been infected with MCMV-
ie/-VAC and were used as effector cells in a standard 3 hr cytolytic 
assay (Dei Val et al. , 1988). Graded numbers of cytolytic effector cells 
in 2-fold or 3-fold dilution steps were used. Data represent the mean 
percentage of specific lysis from three replicate cultures. 
Pulse-Chase Analysis 
BALB.SV cells (5 x 106) were labeled for 30 min with 0.5 mCi of 
I"'S]methionine (1200 Ci/mmol) in methionine-free medium 8 hr after 
infection with recombinant vaccinia viruses. Incorporation was term i-
nated by the addition of nonradioactive methionine to a final concentra-
tion of 0.45 mM. Cells were then chased for 0, 1, and 4 hr in normal 
culture medium. At each chase time, sam pies were taken and sub-
jected to two rounds of immunoprecipitation with an antiserum recog-
nizing both HBcAg and HBeAg (Schlicht, 1991). 
Isolation of Naturally Processed Peptides 
BALB.SV cells were infected in parallel with all mentioned recombinant 
vaccinia viruses at a multiplicity of infection of 3 pfu per cell, and 20 
hr later, naturally processed peptides were extracted in parallel from 
whole cells with trifluoroacetic acid as described (Rötzschke et al. , 
1990b). Briefly, trifluoroacetic acid-soluble material was separated 
first on a Sephadex G25 column and sUbsequentlyon an HPLC 
reverse-phase column. Lyophilized fractions were resuspended, di-
luted in RPMI 1640 culture medium, and dispensed into microtiter 
plates. 51Cr-labeled BALB.SV cells were then added and, after 1 hr 
of incubation, pp89-specific cytolytic effector cells were added for a 
standard 3 hr cytolytic assay. Naturally processed peptides from cells 
infected with all recombinant viruses were tested in parallel. 
Protection In Vlvo 
Mice were immunized i.v. with 1 x 10" pfu of recombinant vaccinia 
viruses and challenged i.p. 3 weeks later with 3 LDsos of MCMV, strain 
Smith (VR-194; American Type Culture Collection, Rockville, MD), iso-
lated from the salivary glands of infected mice (Jonjic et al. , 1988). 
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